Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines

Melanoma and Skin Cancer

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas

J Eur Acad Dermatol Venereol.

Morton CA, Szeimies RM, Basset-Seguin N, Calzavara-Pinton P, Gilaberte Y, Haedersdal M, Hofbauer GFL, Hunger RE, Karrer S, Piaserico S, Ulrich C, Wennberg AM, Braathen LR

doi: 10.1111/jdv.16017.

Melanoma and Skin Cancer

Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review

JAMA Dermatol.

Schauder DM, Kim J, Nijhawan RI

doi: 10.1001/jamadermatol.

Melanoma and Skin Cancer

Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma

J Invest Dermatol.

Dusingize JC, Olsen CM, Pandeya NP, Subramaniam P, Thompson BS, Neale RE, Green AC, Whiteman DC; QSkin Study

doi: 10.1016/j.jid.2017.03.027.

Melanoma and Skin Cancer

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

J Eur Acad Dermatol Venereol.

Dummer R, Ascierto PA, Basset-Seguin N, Dréno B, Garbe C, Gutzmer R, Hauschild A, Krattinger R, Lear JT, Malvehy J, Schadendorf D, Grob RJJ

doi: 10.1111/jdv.16230.

Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma

Dermatol Surg.

Bostanci S, Kocyigit P, Vural S, Heper AO, Botsali A

doi: 10.1097/

Immunotherapy

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017

Eur J Cancer.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R

doi: 10.1016/j.ejca.2017.02.027.

Melanoma and Skin Cancer

Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial

Br J Dermatol.

Kessels JPHM, Kreukels H, Nelemans PJ, Roozeboom MH, van Pelt H, Mosterd K, de Haas ERM, Kelleners-Smeets NWJ

doi: 10.1111/bjd.1596.

Melanoma and Skin Cancer

Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States

JAMA Dermatol

Lukowiak TM, Aizman L, Perz A, Miller CJ, Sobanko JF, Shin TM, Giordano CN, Higgins HW 2nd, Etzkorn JR

doi: 10.1001/jamadermatol.2020.2571

RECOMMENDED

Melanoma and Skin Cancer

Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma

J Am Acad Dermatol.

Wei EX, Li X, Nan H

doi: 10.1016/j.jaad.2018.09.044.

Related content

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas

Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review

Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017

Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial

Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States

Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma